Cladis Investment Advisory’s GE HealthCare GEHC Stock Holding History

Cladis Investment Advisory’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.22M	Sell	17,168 -14	-0.1%	-$1.1K	0.67%	47
2025 Q4	$1.41M	Buy	17,182 +3,072	+22%	+$239K	0.77%	39
2025 Q3	$1.06M	Sell	14,110 -199	-1%	-$14.8K	0.61%	54
2025 Q2	$1.06M	Sell	14,309 -13	-0.1%	-$905	0.66%	48
2025 Q1	$1.16M	Sell	14,322 -84	-0.6%	-$7.22K	0.84%	36
2024 Q4	$1.13M	Sell	14,406 -420	-3%	-$35.7K	0.8%	42
2024 Q3	$1.39M	Buy	14,826 +188	+1%	+$15.8K	0.96%	32
2024 Q2	$1.14M	Buy	14,638 +224	+2%	+$18.3K	0.83%	36
2024 Q1	$1.31M	Sell	14,414 -149	-1%	-$12.4K	0.96%	34
2023 Q4	$1.13M	Buy	14,563 +1,826	+14%	+$128K	0.88%	36
2023 Q3	$867K	Buy	12,737 +4,341	+52%	+$316K	0.76%	43
2023 Q2	$682K	Buy	8,396 +109	+1%	+$8.7K	0.59%	57
2023 Q1	$680K	Buy	+8,287	New	+$592K	0.61%	59

Other funds holding GEHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Cladis Investment Advisory's GEHC Position: Q1 2026 in Review

Cladis Investment Advisory reduced its GE HealthCare (GEHC) stake by 0.08% in Q1 2026, selling an estimated $1.1K and leaving 17,168 shares worth $1.22M. The position accounts for 0.67% of the portfolio, ranked #47.

Cladis Investment Advisory first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.41M in Q4 2025. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

Cladis Investment Advisory held 17,168 shares of GE HealthCare worth $1.22M as of Q1 2026.
Cladis Investment Advisory sold 14 GE HealthCare shares in Q1 2026, an estimated $1.1K.
GE HealthCare made up 0.67% of Cladis Investment Advisory's portfolio in Q1 2026, its #47 holding.
Cladis Investment Advisory first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
Cladis Investment Advisory's GE HealthCare position peaked at $1.41M in Q4 2025.
1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Cladis Investment Advisory's 13F filing for Q1 2026, filed 15 May 2026.